Nienke R. Wevers

Nienke R. Wevers

Auto-generated profile, based on publicly available information

Nienke R. Wevers

MIMETAS B.V., De Limes 7, 2342 DH Oegstgeest, The Netherlands

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in SLAS Technology
Verified
Journal Article
Open access
MSMayu Shibuta
Mayu Shibuta
KTKazuhiro Tetsuka
Kazuhiro Tetsuka
TKTetsuhiro Kawabe
Tetsuhiro Kawabe
INIchiji Namatame
Ichiji Namatame
HAHidemitsu Asano
Hidemitsu Asano
HSHaruna Sasaki-Iwaoka
Haruna Sasaki-Iwaoka
The increasing demand for effective and translatable culture models in drug discovery has driven the development of advanced systems, including organ-on-a-chip (OoC), microphysiological systems (MPS), and complex in vitro models (CIVM). These technologies are recognized for their ability to model human physiological responses, particularly with the Food and Drug Administration (FDA) Modernization Act 2.0 promoting cell-based assays and computer simulations as new approach methodologies (NAMs) to reduce reliance on animal testing. However, the adoption of MPS and OoC systems in drug discovery remains limited by complex culture protocols, low throughput, and difficulties in achieving reproducible results. In this study, we demonstrate that our automated platform, "Screening Station No. 2," addresses these challenges by fully automating the end-to-end process-from cell culture to drug testing-using an angiogenesis model. The system integrates the SCALE12-MR rocking incubator with numerous instruments and dynamic scheduling to enable seamless execution of key operations, including media exchange, compound dosing, and imaging. By minimizing human intervention, it automates OoC cultivation, including gravitational stimulation via rocking culture. Screening Station No. 2 supports scalability, expandability, and automation of complex workflows that were previously difficult to implement. This study highlights the importance of versatile, scalable automated systems capable of adapting to diverse experimental conditions to enhance the efficiency and reliability of drug discovery. The advances demonstrate the potential of automated OoC systems to accelerate drug development, improve preclinical model translatability, and address the demand for innovative laboratory automation methodologies.

15 September 2025 in bioRxiv
Verified
Preprint
Open access
JAJade Admiraal
Jade Admiraal
PEPromise Ojoche Emeh
Promise Ojoche Emeh
MBMarleen Bokkers
Marleen Bokkers
TOThomas Olivier
Thomas Olivier
KQKarla Queiroz
Karla Queiroz
NWNienke R. Wevers
Nienke R. Wevers
The blood vessels of the central nervous (CNS) system form a tight, protective blood-brain barrier (BBB). This barrier is essential for healthy CNS function but also poses a hurdle in the treatment of increasingly common neurological disorders. Additionally, BBB dysfunction is a hallmark of many neurological diseases, further emphasizing a need for a better understanding of BBB function in health and disease. We present a human self-assembling 3D model of the BBB in a microfluidic cell culture platform that allows culture of 48 models in parallel on one tissue culture plate. Human brain microvascular endothelial cells, pericytes, and astrocytes form highly reproducible BBB vascular networks under unidirectional perfusion and remain viable for a minimum of 14 days. Immunostaining reveals close cell-cell interactions with pericytes and astrocyte end-feet in direct contact with the brain microvasculature. Compared to endothelial monocultures, co-culture with astrocytes or pericytes results in improved barrier function, lower vessel diameters, increased branching, and alignment of the vessels in the direction of fluid flow. These results were most pronounced in tri-cultures containing all three cell types. Unlike similar models previously reported, this brain microvasculature model allows for unidirectional perfusion without the need for pumps and syringes. Combined with its high-throughput nature, this feature renders the model suitable for studies of BBB function in health and disease, and assessment of potential BBB restorative therapies.